JHL Biotech, Inc. (GTSM:6540) announced a private placement of convertible bonds led by VMS Investment Group (HK) Limited in pre IPO round of funding for gross proceeds of $106,000,000 on May 15, 2018. The transaction also includes participation from existing investors including Kleiner Perkins Caufield & Byers, Sequoia Capital China, Biomark Capital, Milestone Capital Management Limited, CDIB Capital International (Hong Kong) Corporation Limited, and Fidelity Management & Research LLC. The company has raised $320,000,000 in funding till date.